In renal diseases, PINK1/Parkin-mediated mitophagy has been shown to prevent cisplatin-induced apoptosis of renal tubular epithelial cells and tissue damage both in vivo and in vitro (Wang et al. 2018). This evidence concerns the gene PRKN and kidney disorder.